Matches in Nanopublications for { ?s ?p "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP115407.RAmiI8nyOVx08VeClelGyo7LkGR6oBnolnKfK7bn-TuZQ130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115407.RAmiI8nyOVx08VeClelGyo7LkGR6oBnolnKfK7bn-TuZQ130_provenance.
- NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP114603.RA8o1JE_pkJ43U_er8n40rR2uaT6vIOiSrMYJiSb7xp4w130_provenance.
- assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP201519.RAT84OfXaIu3rTBMjvWRXm4ZlWwQkgM8iCeHMU35ZCcSE130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201519.RAT84OfXaIu3rTBMjvWRXm4ZlWwQkgM8iCeHMU35ZCcSE130_provenance.
- NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201520.RAV1s15WpHNA0UrDf5VsSDwyS-O1UfqeklOeeBEr1RwLo130_provenance.
- NP178609.RADnxFYOCaLX2dC44KKHEwolpqUPAulqclvTMGMFF_asQ130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP178609.RADnxFYOCaLX2dC44KKHEwolpqUPAulqclvTMGMFF_asQ130_provenance.
- NP177808.RAHF-lNU--5RJqjXSb5kGduO02W4isTcJKM9JLdwZ1YDg130_assertion description "[Both BRAF and FBXW7 mutations functionally activate kinase effectors important in pancreatic cancer and extend potential options for therapeutic targeting of kinases in treatment of phenotypically distinct pancreatic adenocarcinoma subsets.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177808.RAHF-lNU--5RJqjXSb5kGduO02W4isTcJKM9JLdwZ1YDg130_provenance.